This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,930.30 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluent. The order has a completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. The company holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,871.32 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of September 16, 2024. It does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, is a supplier of a wide range of prescription medications, over-the-counter drugs,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract, valued at $13,515.30, is for the supply of RABAVERT rabies vaccine with diluents. It is a firm fixed-price contract with a completion date of June 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $15,442.40 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.50, is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $3,860.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, a critical pharmaceutical product to support military and federal healthcare needs. The contract has a ceiling value of $19,303.00 and is a firm fixed-price delivery order, with an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a ceiling value of $9,265.44 and a period of performance through July 2024. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of RABAVERT rabies vaccine with diluents, with a potential value of $2,895.45 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...